Discover 1,134 paid clinical trials in Bridgeport, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,134
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
for
Major Depressive Disorder
Location: Farmington CT, New York NY, Brooklyn NY, Toms River NJ,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 18 - 65
Code: NCT05850689
Phase 3, Recruiting
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
for
Hidradenitis Suppurativa (HS)
Location: Farmington CT, Boston MA, Danville PA, Baltimore MD,
Sponsor: Incyte Corporation
Sex: All
Age: 12 - 17
Code: NCT07213973
Phase 2, Recruiting
Cognitive Remediation
for
Aging, Inflammation, Cognitive Remediation,
Location: Farmington CT
Sponsor: Cutter Lindbergh
Sex: All
Age: 60+
Code: NCT07171450
Recruiting
Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
for
Myasthenia Gravis
Location: Farmington CT, New York NY, Foxborough MA, Raleigh NC,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18 - 70+
Code: NCT07217587
Phase 3, Recruiting
Daily Amino Acid Supplementation for People With Parkinson's Disease
for
Parkinson Disease (PD)
Location: Farmington CT, Storrs CT
Sponsor: Cristina Colon-Semenza
Sex: All
Age: 50 - 70+
Code: NCT07115563
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Bone Loss, Physical Function and Frailty in Older Women With Sickle Cell Trait Sickle Cell Trait
Targeting Aging With a Ketone Ester for Function in Frailty
for
Frail Elderly, Aging, Immune Function, Muscle Function
Location: Farmington CT, Columbus OH, Novato CA
Sponsor: Buck Institute for Research on Aging
Sex: All
Age: 65+
Code: NCT06645847
Recruiting
Gadopiclenol vs. Gadobutrol for Dynamic Contrast-Enhanced Pituitary MRI (Magnetic Resonance Imaging)
for
Contrast Enhanced Images vs. Non-contrast Images,
Location: Farmington CT
Sponsor: UConn Health
Sex: All
Age: 19+
Code: NCT06846853
Recruiting
Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program
for
Glycogen Storage Disease Type Ia
Location: Hartford CT, Philadelphia PA, Montreal, Durham NC,
Sponsor: Ultragenyx Pharmaceutical Inc
Sex: All
Age: 2+
Code: NCT06636383
Recruiting
Genetic and Functional Analysis of Cherubism
for
Cherubism
Location: Farmington CT
Sponsor: UConn Health
Sex: All
Age: 0+
Code: NCT01630447
Recruiting
Genetic Analysis of Keloids
for
Keloid
Location: Farmington CT
Sponsor: UConn Health
Sex: All
Age: 0+
Code: NCT01619553
Recruiting
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
for
Idiopathic Pulmonary Fibrosis
Location: Farmington CT, New York NY, Philadelphia PA,
Sponsor: Cumberland Pharmaceuticals
Sex: All
Age: 40+
Code: NCT05571059
Phase 2, Recruiting
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
for
Psychosis Associated With Alzheimer's Disease
Location: Farmington CT, Woodmere NY, Matthews NC, Atlanta GA,
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Location: Farmington CT, Birmingham AL, San Diego CA
Sponsor: RAND
Sex: All
Age: 18+
Code: NCT06854757
Recruiting
A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia
for
Cachexia
Location: Shirley NY, Hartford CT, East Brunswick NJ,
Sponsor: AVEO Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT05865535
Phase 1, Recruiting
The Lilac Device Trial - IMPACT: A Clinical Investigation on IMproving Peripheral Neuropathy Induced by Chemotherapy With Advanced Compression Technology - A Safety and Efficacy Study
for
Chemotherapy Induced Peripheral Neuropathy (CIPN)
Location: New York NY, Norwich CT, East Brunswick NJ,
Sponsor: Luminate Medical, Inc.
Sex: All
Age: 18+
Code: NCT07142304
Recruiting
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
for
Pancreatic Cancer, PDAC,
Location: New York NY, Hartford CT, Boston MA, Philadelphia PA,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT07252232
Phase 3, Recruiting
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
for
Carcinoma, Non-Small-Cell Lung
Location: New York NY, Hartford CT, Worcester MA, Philadelphia PA,